Skip links

Real-World Evidence for Patient Insights: How Pharma Can Leverage Social RWE Throughout the Clinical Pipeline

Download our new whitepaper to learn how healthcare brands can leverage Social RWE to better understand the patient journey, identify unmet needs, accelerate drug development and improve pharmacovigilance.

Learn how RWE derived from Big Social Data offers a myriad of benefits to the pharma industry by unlocking previously inaccessible stakeholder insights.

Big Social Data offers an efficient, relevant, and cost-effective RWE source – all while helping build meaningful stakeholder partnerships that can drive competitive advantage.

Learn how to efficiently and compliantly leverage the benefits of social RWE.  Download our new whitepaper to discover our two-tiered model for extracting quality insights from online patient, caregiver and HCP conversations to keep your clinical pipeline safe, efficient and relevant.

Convosphere’s two-tiered model for obtaining Social RWE

Convosphere’s 2-tiered model for extracting quality insights from social media conversation offers stakeholders confidence in social RWE.

Business questions answered in the whitepaper:

• What is the difference between traditional social listening and RWE social listening?

• What real-world data exists in Big Social Data?

• Why does real-world data from social listening matter?

What is the value of social RWE throughout the clinical pipeline – for understanding the patient journey, identifying unmet needs, evaluating outcomes, building enhanced value propositions, accelerating drug development, and improving pharmacovigilance?

Social Insights RWE

Discover how to Unlock Patient Insights with Social RWE.

Download Whitepaper